학술논문

Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease.
Document Type
Article
Source
Clinical Pharmacology & Therapeutics; Dec2017, Vol. 102 Issue 6, p1017-1024, 8p
Subject
AGRANULOCYTOSIS
THYROID antagonists
GRAVES' disease
GENETICS of disease susceptibility
GRANULOCYTES
THERAPEUTICS
Language
ISSN
00099236
Abstract
Copyright of Clinical Pharmacology & Therapeutics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)